4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0002047607-26-000008
Chief Strategy Officer sold 2,655 shares at $19.59 ($52,012)
From the SEC's structured data for this filing
Trades in this filing
Riley Jennifer · Chief Strategy Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-11 | Sale : show line 1 in the form | −2,655 | $19.59 | $52,012 | 37,041 | D |
| Open-market sales · 2,655 sh · avg $19.59 · $52,012 | ||||||
Loading xslF345X06/form4-08122026_040809.xml…